To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·05-21
      ARKG Investment Tracker position change: Decreased position in Veracyte by 5,800 shares, the number of shares held decreased 0.65% compared to the previous period and now represents 3.54% of the total position.
      130Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-21
      ARKG Investment Tracker position change: Decreased position in Natera by 1,585 shares, the number of shares held decreased 0.64% compared to the previous period and now represents 4.5% of the total position.
      181Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-21
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 2,765 shares, the number of shares held decreased 0.64% compared to the previous period and now represents 1.74% of the total position.
      69Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-21
      ARKG Investment Tracker position change: Decreased position in Tempus AI by 13,140 shares, the number of shares held decreased 0.65% compared to the previous period and now represents 8.43% of the total position.
      183Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-21
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 75,870 shares, the number of shares held decreased 0.65% compared to the previous period and now represents 3.22% of the total position.
      384Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-21
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 29,780 shares, the number of shares held decreased 0.65% compared to the previous period and now represents 1.23% of the total position.
      114Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-21
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 12,655 shares, the number of shares held decreased 0.65% compared to the previous period and now represents 2.24% of the total position.
      103Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-21
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 132,580 shares, the number of shares held decreased 1.29% compared to the previous period and now represents 1.11% of the total position.
      805Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-21
      ARKG Investment Tracker position change: Decreased position in Eli Lilly by 75 shares, the number of shares held decreased 0.64% compared to the previous period and now represents 1.11% of the total position.
      80Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·05-21
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 42,300 shares, the number of shares held decreased 1.29% compared to the previous period and now represents 3.92% of the total position.
      176Comment
      Report
      • empty
        No followers yet
       
       
       
       

      Most Discussed